[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CA2002483A1 - Analogue de la fluoxetine - Google Patents

Analogue de la fluoxetine

Info

Publication number
CA2002483A1
CA2002483A1 CA2002483A CA2002483A CA2002483A1 CA 2002483 A1 CA2002483 A1 CA 2002483A1 CA 2002483 A CA2002483 A CA 2002483A CA 2002483 A CA2002483 A CA 2002483A CA 2002483 A1 CA2002483 A1 CA 2002483A1
Authority
CA
Canada
Prior art keywords
fluoxetine
analog
norflu
oxetine
serotonin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2002483A
Other languages
English (en)
Other versions
CA2002483C (fr
Inventor
Ray Ward Fuller
David Wayne Robertson
David Taiwai Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CA2002483A1 publication Critical patent/CA2002483A1/fr
Application granted granted Critical
Publication of CA2002483C publication Critical patent/CA2002483C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002002483A 1988-11-14 1989-11-08 Analogue de la fluoxetine Expired - Fee Related CA2002483C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27017788A 1988-11-14 1988-11-14
US07/270,177 1988-11-14

Publications (2)

Publication Number Publication Date
CA2002483A1 true CA2002483A1 (fr) 1990-05-14
CA2002483C CA2002483C (fr) 1999-08-17

Family

ID=23030229

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002002483A Expired - Fee Related CA2002483C (fr) 1988-11-14 1989-11-08 Analogue de la fluoxetine

Country Status (15)

Country Link
EP (1) EP0369685B1 (fr)
JP (1) JP2776919B2 (fr)
CN (1) CN1042704A (fr)
AU (1) AU622942B2 (fr)
CA (1) CA2002483C (fr)
DE (1) DE68922277T2 (fr)
DK (1) DK560289A (fr)
ES (1) ES2071663T3 (fr)
FI (1) FI895328A0 (fr)
HU (1) HUT58041A (fr)
IL (1) IL92245A0 (fr)
NZ (1) NZ231354A (fr)
PT (1) PT92242B (fr)
SU (1) SU1750417A3 (fr)
ZA (1) ZA898513B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250571A (en) * 1988-11-14 1993-10-05 Eli Lilly And Company (S)-norfluoxetine in method of inhibiting serotonin uptake
FI910897A (fi) * 1990-02-28 1991-08-29 Lilly Co Eli Foerbaettringar roerande (s)-norfluoxetin.
EP0449562A3 (en) * 1990-03-29 1992-03-18 Eli Lilly And Company Use of r-fluoxetine as selective serotonin ic-receptor ligands
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
US5136079A (en) * 1991-02-26 1992-08-04 Eli Lilly And Company Regioselective synthesis
US5136078A (en) * 1991-02-26 1992-08-04 Eli Lilly And Company Synthesis of b-cyanohydrins
AU664031B2 (en) * 1991-03-01 1995-11-02 Monsanto Company Fluoroalkenyl compounds and their use as pest repellents
ES2101650B1 (es) * 1995-06-29 1998-01-16 Lilly Sa Procedimiento de preparacion de n-metil-3-fenil-3-(p-trifluorometilfenoxi) propilamina.
ES2101654B1 (es) * 1995-07-24 1998-01-16 Lilly Sa Procedimiento de preparacion de n-metil-3-fenil-3-(p-trifluorometilfe noxi) propilamina.
ES2101655B1 (es) * 1995-07-28 1998-01-16 Lilly Sa Procedimiento de preparacion de n-metil-3-fenil-3-(p-trifluorometilfe noxi) propilamina.
ES2103682B1 (es) * 1995-09-20 1998-04-01 Lilly Sa Composicion farmaceutica oral de fluoxetina, solida y con caracteristicas organolepticas mejoradas.
ES2120368B1 (es) * 1996-06-14 1999-07-01 Almirall Prodesfarma Sa Procedimiento de obtencion de n-metil-3-(p-trifluorometilfenoxi)-3-fenilpropilamina y sus sales farmaceuticamente aceptables.
US5936124A (en) * 1998-06-22 1999-08-10 Sepacor Inc. Fluoxetine process from benzoylpropionic acid
US6025517A (en) * 1998-08-03 2000-02-15 Sepracor Inc. Fluoxetine process from benzoylacetonitrile
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
US7439399B2 (en) * 2004-06-28 2008-10-21 Teva Pharmaceutical Fine Chemicals Processes for the preparation of atomoxetine hydrochloride
ITMI20061987A1 (it) * 2006-10-16 2008-04-17 Archimica Srl Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626549A (en) 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4313896A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Aryloxyphenylpropylamines
US4868344A (en) * 1988-03-30 1989-09-19 Aldrich-Boranes, Inc. Novel process of producing phenyl or substituted phenylalkylamine pharmaceutical agents and novel chiral intermediates of high enantiomeric purity useful therein

Also Published As

Publication number Publication date
DK560289D0 (da) 1989-11-09
JPH02193951A (ja) 1990-07-31
EP0369685A2 (fr) 1990-05-23
HUT58041A (en) 1992-01-28
NZ231354A (en) 1991-05-28
PT92242B (pt) 1995-07-06
HU895848D0 (en) 1990-01-28
JP2776919B2 (ja) 1998-07-16
PT92242A (pt) 1990-05-31
EP0369685B1 (fr) 1995-04-19
AU4451689A (en) 1990-05-17
IL92245A0 (en) 1990-07-26
DE68922277T2 (de) 1995-09-21
AU622942B2 (en) 1992-04-30
ZA898513B (en) 1991-07-31
EP0369685A3 (fr) 1991-03-27
CA2002483C (fr) 1999-08-17
FI895328A0 (fi) 1989-11-09
ES2071663T3 (es) 1995-07-01
SU1750417A3 (ru) 1992-07-23
DK560289A (da) 1990-05-15
DE68922277D1 (de) 1995-05-24
CN1042704A (zh) 1990-06-06

Similar Documents

Publication Publication Date Title
CA2002483A1 (fr) Analogue de la fluoxetine
GB8920597D0 (en) Pharmaceutical compositions comprising cyclosporins
IL91404A0 (en) Substituted 4-azatricyclo(22.3.1.0 4,9)octacos-18-ene derivations,their preparation and pharmaceutical compositions containing them
NZ232084A (en) Amino-phenyl-n-heterocyclic (ring b) compounds and pharmaceutical compositions
IL107978A0 (en) Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
PH30439A (en) 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same
HK19496A (en) Use of 1,2,2,3,3-penta-fluoropropane
NZ218615A (en) S-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride monohydrate and local anesthesia compositions
IL109275A0 (en) 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
NZ230356A (en) 2',3'-dideoxy-5-ethynyl-3'-fluorouridine: preparatory processes and pharmaceutical compositions
ZA897614B (en) Substituted 1,3,5-triazinetriones,processes for their preparation and their use against parasitic protozoa
IL93339A0 (en) 2,3,23-trihydroxy-urs-12-ene and its derivatives,processes for their preparation and their use
EP0461261A4 (fr) Melange d'oligopeptides et preparation le contenant.
HU9403653D0 (en) New pharmaceutical use of 1,2,3,4,4a,5,10,10a-octahydro-benzo(g) quinoline derivatives
NZ239547A (en) Hydrogenated indolo(1,7-bc)(2,6)naphthyridine derivatives and pharmaceutical compositions
EP0650723A3 (fr) Nouvelles utilisations pharmaceutiques des dérivés de la forskoline.
CA2018461A1 (fr) Polypeptides et leur utilisation
NZ227235A (en) Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions
IL90652A (en) 8,9-annelated-b-carboline and -3,4-dihydro-b- carboline derivatives, their preparation and pharmaceutical compositions containing them
AU6764890A (en) 1,3-disubstituted 5-azolyloxy-phenylcarbomyl-4, 6-pyrimidinedione derivatives and the hydrogenated analogues thereof
IL90407A0 (en) Pharmaceutical compositions comprising 1,2-dithiol-3-thion-s-oxide derivatives,certain such new derivatives and their preparation
ZA907894B (en) Substituted 1,3,4-thiadiazolinones,processes for their preparation,and their use for combating endoparasites
EP0373416A3 (en) Mixture of 3,1-benzooxazines and fluoranes
NZ224728A (en) 3-acylaminomethyl-5,6,7,8-tetrahyd-pyridine derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed